Jan 12, 2026
Which clinical trials report 35% or 50% reductions attributed to statins and what outcomes do they measure?
Clinical trials and meta-analyses attribute reductions in lipid levels and cardiovascular events to statins in two different senses: percentage reductions in LDL cholesterol (biomarker change) and per...